… study, we prospectively followed 470 asymptomatic carriers of the factor V Leiden mutation
for … In conclusion, the absolute annual incidence of spontaneous venous thromboembolism is …

… Factor V Leiden is a common thrombophilic mutation. METHODS: The prospective outcome
of untreated pregnancies amongst 25 women heterozygous for the Factor V Leiden allele …

… studies prospectively assessing the association of heterozygous factor V Leiden (FVL) …
mutation (patients); recurrent VTE (outcome); and prospective cohort study (study design). The …

The conclusions of studies to date which evaluate a possible association between factor V
Leiden and adverse pregnancy outcome have been conflicting. This study was undertaken to …

… clinical perspective, screening programs for factor V Leiden … 13 In brief, the PHS is a
prospective cohort of 22 071 US male … concerning risk factors and disease outcomes. For any self-…

… the Factor V Leiden and prothrombin G20210A mutation are associated with recurrent venous
thromboembolism in a prospective … In conclusion, our results demonstrate that in elderly …

… in individuals with and without the factor Leiden mutation. … 87 In a prospective study, Factor
V Leiden heterozygotes with a … no benefit of LMWH on pregnancy outcome. There are no …

… VTE, and the outcome of patients presenting with … factor VIII:C, which have been reported
to have the potential to increase the risk associated with FVL or PTM carriage.14 In conclusion, …

… Because the outcome of probands was either a first or recurrent venous thrombotic event, …
A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine …

… Thus, our findings suggest that the presence of factor V Leiden mutation should be
considered in future studies aiming to identify patients with venous thromboembolism at risk for …